All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
Children can develop Post COVID Syndrome (PCS) even if they were asymptomatic during the acute phase of the infection.
Problems include fatigue, breathlessness, headache, chest pain and palpitations. Children and Young People (CYP) with Long COVID miss significant amounts of education and social and family activities.
Most presentations in children and adolescents are similar to Post-Viral Fatigue and ME/CFS and existing pathways can be used/adapted to support children and young people with Long COVID
With
And
And
And
Please note that patients whose symptoms predate the pandemic and have not changed as a result of COVID infection are NOT appropriate for this service
Western: Young people aged over 16 years can be referred using the adult long Covid pathway
Northern, Eastern and Southern: 16–18-year-olds can also be referred via the adult long Covid pathway
Many CYP will experience the following symptoms (and therefore reassure):
From the evidence available so far, we know that the main symptoms with which children are presenting are:
It is recommended that if the parent or patient thinks they have had COVID infection, been in contact with someone who has had it, or had a positive test and has ongoing symptoms the diagnosis of Post COVID should be considered.
12 weeks of persistent symptoms is the typical point of referral for adults. Children may be referred earlier than this, between 4-12 weeks, if the GP is concerned. Should this be considered necessary the GP is advised to discuss via phone with a local paediatrician initially, or via advice and guidance prior to formal referral.
The following information is a guide for primary care professionals assessing CYP with suspected Post COVID
We are aware that these symptoms are consistent with several other conditions, and some may reflect the impact of the pandemic on children. To help you to distinguish between children with suspected post covid and those with other conditions we recommend you consider if there has been a stepwise /quantum change in the patient’s behaviour or symptomatology realistically chronologically related to COVID contact or illness?
If there is clinical doubt, then please seek advice via an A&G referral, ensuring the request is directed to the named PCS Consultants for each trust:
Southern: Dr Richard Tozer
Western: Dr Samuel Broad
Eastern: Please write for A&G to general paediatrics
Northern: Dr Dermot Dalton
Send sick children to ED / children’s assessment unit as you always do according to the traffic light system. If in doubt discuss with secondary care (be prepared with a set of observations and your reasons for being uneasy)
Other red flag symptoms:
Note: Sudden onset & termination of fast HR suggests pathway mediated tachycardia. This is not
COVID related so check for symptoms before COVID infection.
PIMS-TS is a rare, serious condition caused by COVID. All children will have a fever, which persists over several days. There’s a very wide range of other symptoms that children might have, including: abdominal pain, diarrhoea, vomiting, rash, cold hands and feet and red eyes. Children in whom PIMS-TS needs to be considered will usually appear ‘sick’ and have one or more ‘red flags’.
Laboratory Tests may be considered and tailored upon presenting symptoms:
Please note: these investigations are suggested and not mandatory for referrals.
Advice about how children with PCS can be managed in primary care
Although the condition can be debilitating and worrying for the child and their family, it is anticipated that the vast majority of children will go on to make a full recovery.
Most children with PCS can be managed in primary care through simple interventions such as:
Resources specific to Children and Young People are being developed for NHSE. Your COVID Recovery | Supporting your recovery after COVID-19 has an adult focus and may or may not be helpful for individual children and young people.
Long COVID Kids is parent led and reasonably balanced and appropriate.
Action for ME is a useful source for managing fatigue symptoms in Long COVID
GPs should normally refer the following to their local Paediatric service:
Acute COVID (less than 4 weeks) – Urgent/Same Day referral if signs, symptoms, or investigations suggest significant or serious illness including but not limited to PIMS-TS
Ongoing Symptomatic COVID (4-12 weeks) – Consider referral depending on symptoms (particularly if organ impairment is suspected, or worsening general symptoms)
Post COVID Syndrome (over 12 weeks) – Refer any children and young people with ongoing symptoms.
Only a small number of children will require specialist intervention by a tertiary centre. GPs are asked to refer to their usual paediatric team.
The investment into PCS services nationally and regionally is primarily for assessment and not treatment. Patients (adults and children) will therefore be routinely referred into existing treatment or rehab pathways. As you are aware, there are now long waiting lists across the NHS so the patient may need to be made aware that they could be waiting some time.
e-Referral Service Selection
Specialty: Children and adolescent
Clinic Type: General
Service:
Advice & Guidance - please direct to the Paediatric Long Covid named clinician below in locality:
Southern: Dr Richard Tozer
Western: Dr Samuel Broad
Eastern: Please refer A&G via general paediatrics
Northern: Dr Dermot Dalton
Resources specific to Children and Young People are being developed for NHSE. Your COVID Recovery | Supporting your recovery after COVID-19 has an adult focus and may or may not be helpful for individual children and young people.
Long COVID Kids is parent led and reasonably balanced and appropriate.
Action for ME is a useful source for managing fatigue symptoms in Long COVID
This guideline has been signed off on behalf of the NHS Devon.
Publication date: July 2022